Press Releases

2005

November 9, 2005
MIP Technologies and CDC publish improved method for monitoring tobacco-derived carcinogen.
 Read more (pdf)

August 23, 2005
MIP Technologies Raises SEK 30 million (USD3.9M).
 Read more (pdf)
 Read more (pdf) [Swedish]

July 19, 2005
MIP Technologies enters into contract with US Environmental Protection Agency (EPA).
New contract with US administration follows work for CDC in Atlanta.
 Read more (pdf)

March 17, 2005
MIP Technologies launches MIP4SPE-Triazine10, a SPE sorbent for multi-residue extraction of 10 different triazines and triazine metabolites.
 Read more (pdf)
 Read more (pdf) [Swedish]

January 21, 2005
MIP Technologies and FeF Chemicals, a subsidiary of Novo Nordisk, sign Research and Development Agreement.
 Read more (pdf)

January 17, 2005
MIP Technologies launches MIP4SPE-Riboflavin, an SPE sorbent selective for the water-soluable vitamin B2 (Riboflavin).
 Read more (pdf)
 Read more (pdf) [Swedish]

2004

August 27, 2004
MIP Technologies launches MIP4SPE-NNAL, an SPE sorbent selective for the carcinogenic nicotine metabolite, NNAL.
 Read more (pdf)
 Read more (pdf) [Swedish]

July 1, 2004
MIP Technologies introduces MIP4SPE β-Agonist, an SPE sorbent selective for a large range of beta-agonists.
 Read more (pdf)
 Read more (pdf) [Swedish]